Stock Scorecard
Stock Summary for Applied Dna Sciences Inc (APDN) - $0.29 as of 4/24/2024 3:24:31 PM EST
Total Score
11 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for APDN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for APDN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for APDN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for APDN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for APDN
Financial Details for APDN
Company Overview |
|
---|---|
Ticker | APDN |
Company Name | Applied Dna Sciences Inc |
Country | USA |
Description | Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the pre-clinical drug development and manufacturing markets based on nucleic acid-based in vitro diagnostics; and for supply chain security, anti-counterfeiting, and anti-theft technology applications in the United States, Europe, and Asia. The company is headquartered in Stony Brook, New York. |
Sector Name | TRADE & SERVICES |
Industry Name | SERVICES-MISCELLANEOUS BUSINESS SERVICES |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/9/2024 |
Stock Price History |
|
Last Day Price | 0.29 |
Last Day Price Updated | 4/24/2024 3:24:31 PM EST |
Last Day Volume | 847,898 |
Average Daily Volume | 154,013 |
52-Week High | 1.86 |
52-Week Low | 0.31 |
Last Price to 52 Week Low | 6.45% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 69.15 |
Sector PE | 39.28 |
5-Year Average PE | -2.47 |
Free Cash Flow Ratio | 1.45 |
Industry Free Cash Flow Ratio | 30.05 |
Sector Free Cash Flow Ratio | 84.41 |
Current Ratio Most Recent Quarter | 1.77 |
Total Cash Per Share | 0.20 |
Book Value Per Share Most Recent Quarter | 0.31 |
Price to Book Ratio | 1.52 |
Industry Price to Book Ratio | 62.56 |
Sector Price to Book Ratio | 8.75 |
Price to Sales Ratio Twelve Trailing Months | 0.72 |
Industry Price to Sales Ratio Twelve Trailing Months | 1.61 |
Sector Price to Sales Ratio Twelve Trailing Months | 1.87 |
Share Statistics |
|
Total Shares Outstanding | 16,978,700 |
Market Capitalization | 4,923,823 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.22% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -20.31% |
Reported EPS 12 Trailing Months | -0.55 |
Reported EPS Past Year | -0.09 |
Reported EPS Prior Year | -0.75 |
Net Income Twelve Trailing Months | -7,208,787 |
Net Income Past Year | -9,947,059 |
Net Income Prior Year | -8,267,891 |
Quarterly Revenue Growth YOY | -83.10% |
5-Year Revenue Growth | 27.98% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 3,359,045 |
Total Cash Past Year | 7,151,800 |
Total Cash Prior Year | 15,215,285 |
Net Cash Position Most Recent Quarter | 3,359,045 |
Net Cash Position Past Year | 7,151,800 |
Long Term Debt Past Year | 0 |
Long Term Debt Prior Year | 2,345,903 |
Total Debt Most Recent Quarter | 0 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 4,951,159 |
Total Stockholder Equity Prior Year | 12,911,829 |
Total Stockholder Equity Most Recent Quarter | 4,232,330 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.04 |
MACD Signal | -0.04 |
20-Day Bollinger Lower Band | 0.31 |
20-Day Bollinger Middle Band | 0.53 |
20-Day Bollinger Upper Band | 0.75 |
Beta | 0.09 |
RSI | 32.52 |
50-Day SMA | 0.95 |
200-Day SMA | 3.73 |
System |
|
Modified | 4/23/2024 5:38:05 PM EST |